Images of three receptor tyrosine kinases (IMAGE)

Society of Nuclear Medicine and Molecular Imaging

Images of three receptor tyrosine kinases

Caption

Three receptor tyrosine kinases (RTKs)--EGFR (orange), HER2 (pink), and MET (green)--are imaged before and after the use of a MET-selective tyrosine kinase inhibitor (Trametinib), and trametinib, a mitogen activated protein kinase (MEK) inhibitor, showing its potential effectiveness for treating a tumor.

Credit

Image created by Patricia Pereira, PhD, Research Associate at Memorial Sloan Kettering Cancer Center

Usage Restrictions

Please give appropriate credit.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.